Gamma Investing LLC Alkermes Plc. Transaction History
Gamma Investing LLC
- $18.8 Billion
- Q1 2025
A detailed history of Gamma Investing LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Gamma Investing LLC holds 178,176 shares of ALKS stock, worth $5.58 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
178,176
Previous 4,091
4255.32%
Holding current value
$5.58 Million
Previous $118 Million
95.41%
% of portfolio
0.03%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding ALKS
# of Institutions
410Shares Held
177MCall Options Held
229KPut Options Held
436K-
Black Rock Inc. New York, NY29.1MShares$911 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$570 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.8MShares$369 Million0.05% of portfolio
-
State Street Corp Boston, MA8.02MShares$251 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY6.88MShares$215 Million3.72% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.14B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...